Molecular Aspects of Poliovirus Biology with a Special Focus on the Interactions with Nerve Cells

References

• Abe S, Ota Y, Doi Y, Nomoto A, Nomura T, Chumakov K M, Hashizume S. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus. Virology 1995; 210: 160–166
   Google Scholar
• Ackermann W W, Kurtz H. Observations concerning a persisting infection of HeLa cells with poliomyelitis virus. J Exp Med 1955; 102: 555–565
   Google Scholar
• Agol V I. The 5'-untranslated region of picornaviral genomes. Adv Virus Res 1991; 40: 103–180
   PubMedGoogle Scholar
• Agol V I. Poliovirus neurovirulence and its attenuation. Regulation of gene expression in animal viruses, L Carrasco. Plenum Press, New York 1993; 305–321
   Google Scholar
• Agol V I, Drozdov S G, Grachev V P, Kolesnikova M S, Kozlov V G, Ralph N M, Romanova L I, Tolskaya E A, Tyufanov A V, Viktorova E G. Recombinants between attenuated and virulent strains of poliovirus type 1: derivation and characterization of recombinants with centrally located crossover points. Virology 1985; 143: 467–477
   Google Scholar
• Agol V I, Drozdov S G, Ivannikova T A, Kolesnikova M S, Korolev M B, Tolskaya E A. Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma. J Virol 1989; 63: 4034–4038
   Google Scholar
• Agre J C, Rodriguez A A, Sperling K B. Symptoms and clinical impressions of patients seen in a postpolio clinic. Arch Phys Med Rehabil 1989; 70: 367–370
   PubMed Web of Science ®Google Scholar
• Ahmed R, Morrison L A, Knipe D M. Viral persistence. Viral pathogenesis, N Nathanson. Lippincott-Raven Publisher, Philadelphia 1997; 181–205
   Google Scholar
• Aldabe R, Irurzun A, Carrasco L. Poliovirus protein 2BC increases cytosolic free calcium concentrations. J Virol 1997; 71: 6214–6217
   Google Scholar
• Ambros V, Petterson R F, Baltimore D. An enzymatic activity in uninfected cells that cleaves the linkage between poliovirus RNA and the 5' terminal protein. Cell 1978; 15: 1439–1446
   PubMed Web of Science ®Google Scholar
• Andino R, Rieckhof G E, Achacoso P L, Baltimore D. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA. EMBO J 1993; 12: 3587–3598
   PubMed Web of Science ®Google Scholar
• Andino R, Rieckhof G E, Baltimore D. A fonctional ribonucleoprotein complex forms around the 5' end of poliovirus RNA. Cell 1990; 63: 369–380
   PubMed Web of Science ®Google Scholar
• Andrews N C, Levin D, Baltimore D. Poliovirus replicase stimulation by terminal uridyl transferase. J Biol Chem 1985; 260: 7628–7635
   PubMed Web of Science ®Google Scholar
• Ansardi D, Porter D, Anderson M, Morrow C. Poliovirus assembly and encapsidation of genomic RNA. Adv Virus Res 1996; 46: 1–68
   PubMed Web of Science ®Google Scholar
• Armstrong C. Successful transfer of the Lansing strain of poliomyelitis virus from the cotton rat to the white mouse. Publ Health Rep Wash 1939; 54: 2302–2305
   Google Scholar
• Barco A, Carrasco L. A human virus protein, poliovirus protein 2BC, induces membrane proliferation and blocks the exocytic pathway in the yeast Saccharomyces cerevisiae. EMBO J 1995; 14: 3349–3364
   Google Scholar
• Barnert R H, Zeichhardt H, Habermehl K O. Identification of 50-kDa and 23-/25-kDa HeLa cell membrane glycoproteins involved in poliovirus infection: occurrence of poliovirus specific binding sites on susceptible and nonsusceptible cells. Virology 1992; 186: 533–542
   Google Scholar
• Barton D J, Black E P, Flanegan J B. Complete replication of poliovirus in vitro: preinitiation RNA replication complexes require soluble cellular factors for the synthesis of VPg-linked RNA. J Virol 1995; 69: 5516–5527
   PubMedGoogle Scholar
• Basavappa R, Syed R, Flore O, Icenogle J P, Filman D J, Hogle J M. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 angstrom resolution. Protein Sci 1994; 3: 1651–1669
   PubMed Web of Science ®Google Scholar
• Belsham G J, Sonenberg N. RNA-Protein interactions in regulation of picornavirus RNA translation. Microbiol Rev 1996; 60: 499–511
   PubMedGoogle Scholar
• Bernhardt G, Harber J, Zibert A, De Crombrugghe M, Wimmer E. The poliovirus receptor: identification of domains and amino acid residues critical for virus binding. Virology 1994; 203: 344–356
   Google Scholar
• Bienz K, Egger D, Troxler M, Pasamontes L. Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region. J Virol 1990; 64: 1156–1163
   Google Scholar
• Bienz K, Egger D, Wolff D A. Virus replication, cytopathology, and lysosomal enzyme response of mitotic and interphase HEp-2 cells infected with poliovirus. J Virol 1973; 11: 565–574
   Google Scholar
• Bienz K D, Egger D, Rasser Y, Bossart W. Intracellular distribution of poliovirus proteins and the induction of virus-specific cytoplasmic structures. Virology 1983; 131: 39–48
   Google Scholar
• Blyn L B, Swiderek K M, Richards O, Stahl D C, Semler B L, Ehrenfeld E. Poly(rc) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography tandem mass spectrometry. Proc Natl Acad Sci USA 1996; 93: 11115–11120
   PubMed Web of Science ®Google Scholar
• Bodian D. Poliomyelitis: pathogenesis and histopathology. Viral and rickettsial infections in man, 3rd ed., T M Rivers, F L Horstall. Lippincott, Philadelphia 1959; 479–498
   Google Scholar
• Bodian D, Horstmann D M. Polioviruses. Viral and rickettsial infections of man, F L Horsfall, I Tamm. Lippincott, Philadelphia 1965; 430–473
   Google Scholar
• Bodian D, Howe H A. Emerging concept of poliomyelitis infection. Science 1955; 122: 105–108
   PubMed Web of Science ®Google Scholar
• Borman A, Le Mercier P, Girard M, Kean K. Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res 1997; 25: 925–932
   PubMed Web of Science ®Google Scholar
• Borman A M, Deliat F G, Kean K M. Sequences within the poliovirus internal ribosome entry segment control viral RNA synthesis. EMBO J 1994; 13: 3149–3157
   PubMedGoogle Scholar
• Borzakian S, Couderc T, Barbier Y, Attal G, Pelletier I, Colbere-Garapin F. Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology 1992; 186: 398–408
   PubMed Web of Science ®Google Scholar
• Borzakian S, Pelletier I, Calvez V, Colbere-Garapin F. Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells. J Virol 1993; 67: 2914–2917
   Google Scholar
• Bouchard M J, Lam D H, Racaniello V R. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol 1995; 69: 4972–4978
   PubMed Web of Science ®Google Scholar
• Brown R H, Johnson D, Ogonowski M, Weiner H L. Type 1 human poliovirus binds to human synaptosomes. Ann Neurol 1987; 21: 64–70
   PubMedGoogle Scholar
• Bruneau P, Blondel B, Crainic R, Horodniceanu F, Girard M. Poliovirus type 1 capsid polypeptides: absence of a free form in the cytoplasm of infected HeLa cells. Ann Institut Pasteur/Virologie 1983; 134E: 151–164
   Google Scholar
• Buc-Caron M H. Neuroepithelial progenitor cells explanted from human fetal brain proliferate and differentiate in vitro. Neurobiol Dis 1995; 2: 37–47
   PubMedGoogle Scholar
• Caliguiri L A, Tamm I. Membranous structures associated with translation and transcription of poliovirus RNA. Science 1969; 166: 885–886
   Google Scholar
• Caliguiri L A, Tamm I. The role of cytoplasmic membranes in poliovirus biosynthesis. Virology 1970; 42: 100–110
   PubMed Web of Science ®Google Scholar
• Calvez V, Pelletier I, Borzakian S, Colbere-Garapin F. Identification of a region of the poliovirus genome involved in persistent infection of HEp-2 cells. J Virol 1993; 67: 4432–4435
   Google Scholar
• Calvez V, Pelletier I, Couderc T, Pavio-Guédo N, Blondel B, Colbere-Garapin F. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants. Virology 1995; 212: 309–322
   Google Scholar
• Carp R I. Persistent infection of human lymphoid cells with poliovirus and development of temperature-sensitive mutants. Intervirology 1981; 15: 49–56
   Google Scholar
• Chen W, Baric R S. Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J Virol 1996; 70: 3947–3960
   PubMed Web of Science ®Google Scholar
• Cho M W, Richards O C, Dmitrieva T M, Agol V I, Ehrenfeld E. RNA duplex unwinding activity of poliovirus RNA-dependent RNA polymetase 3Dpol. J Virol 1993; 67: 3010–3018
   Google Scholar
• Cho M W, Teterina N, Egger D, Bienz K, Ehrenfeld E. Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology 1994; 202: 129–145
   PubMed Web of Science ®Google Scholar
• Christodoulou C, Colbère-Garapin F, Macadam A, Taffs L F, Marsden P, Minor P, Horaud F. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol 1990; 64: 4922–4929
   PubMed Web of Science ®Google Scholar
• Clark M E, Dasgupta A. A transcriptiotially active form of TFIIIC is modified in poliovirus-infected HeLa cells. Mol Cell Biol 1990; 10: 5106–5113
   PubMedGoogle Scholar
• Clark M E, Hammerle T, Wimmer E, Dasgupta A. Poliovirus proteinase-3C converts an active form of transcription factor-IIIC to an inactive form: a mechanism for inhibition of host cell polymerase-III transcription by poliovirus. EMBO J 1991; 10: 2941–2947
   PubMedGoogle Scholar
• Clark M E, Lieberman P M, Berk A J, Dasgupta A. Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol Cell Biol 1993; 13: 1232–1237
   PubMedGoogle Scholar
• Colbere-Garapin F, Christodoulou C, Crainic R, Pelletier I. Persistent poliovirus infection of human neuroblastoma cells. Proc Natl Acad Sci USA 1989; 86: 7590–7594
   Google Scholar
• Colonno R J, Condra J H, Mizutani S, Callahan P L, Davies M E, Murcko M A. Evidence for the direct involvement of the rhinovirus canyon in receptor binding. Proc Natl Acad Sci USA 1988; 85: 5449–5453
   PubMed Web of Science ®Google Scholar
• Colston E, Racaniello V R. Soluble receptorresistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J 1994; 13: 5855–5862
   PubMed Web of Science ®Google Scholar
• Colston E M, Racaniello V R. Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J Virol 1995; 69: 4823–4829
   Google Scholar
• Contreras G, Summers D F, Maizel J V, Ehrenfeld E. HeLa cell nucleolar RNA synthesis after poliovirus infection. Virology 1973; 53: 120–129
   PubMedGoogle Scholar
• Couderc T, Christodoulou C, Kopecka H, Marsden S, Taffs L F, Crainic R, Horaud F. Molecular pathogenesis of neural lesions induced by poliovirus type 1. J Gen Virol 1989; 70: 2907–2918
   Google Scholar
• Couderc T, Delpeyroux J, Le Blay H, Blondel B. Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating. J Virol 1996; 70: 305–312
   Google Scholar
• Couderc T, Guédo N, Calvez V, Pelletier I, Hogle J, Colbère-Garapin F, Blondel B. Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mico. J Virol 1994; 68: 8386–8391
   Google Scholar
• Couderc T, Hogle J, Le Blay H, Horaud F, Blondel B. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VPl and VP2 located on the inner surface of the capsid protein shell. J Virol 1993; 67: 3808–3817
   Google Scholar
• Couderc T, Martin A, Wychowski C, Girard M, Horaud F, Crainic R. Analysis of neutralization-excape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted. J Gen Virol 1991; 72: 973–977
   Google Scholar
• Curry S, Chow M, Hogle J M. The poliovirus 135S particle is infectious. J Virol 1996; 70: 7125–7131
   Google Scholar
• Dalakas M C. New neuromuscular symptoms in patients with old poliomyelitis: a three year follow-up study. Eur Neurol 1986; 25: 381–387
   Google Scholar
• Dalakas M C. The post-polio syndrome as an evolved clinical entity. Definition and clinical description. The post-polio syndrome, M C Dalakas, H Bartfeld, L T Kurland. The New York Academy of Sciences, New York 1995; 68–80
   Google Scholar
• Dalakas M C, Sever J L, Madden D L, Papadopoulos N M, Shekarchi I C, Albrecht P, Krezlewicz A. Late postpoliomyelitis muscular atrophy: clinical, virologic, and immunologic studies. Rev Infect Dis 1984; 6(Suppl 2)S562–S567
   PubMedGoogle Scholar
• Dales S, Eggers H J, Tamm I, Palade G E. Electron microscopic study of the formation of poliovirus. Virology 1965; 26: 379–389
   PubMed Web of Science ®Google Scholar
• Dasgupta A, Zabel P, Baltimore D. Dependence of the activity of the poliovirus replicase on a host cell protein. Cell 1980; 19: 423–429
   PubMed Web of Science ®Google Scholar
• de la Torre J C, Martinez-Salas E, Diez J, Villaverde A, Gebauer F, Rocha E, DaVila M, Domingo E. Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease in cell culture. J Virol 1988; 62: 2050–2058
   Google Scholar
• del Angel R M, Papavassiliou A G, Fernandez-Tomas C, Silverstein S J, Racaniello V R. Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA. Proc Natl Acad Sci USA 1989; 86: 8299–8303
   PubMed Web of Science ®Google Scholar
• Dermody T S, Nibert M L, Wetzel J D, Tong X, Fields B N. Cells and viruses with mutations affecting viral entry are selected during persistent infections of L cells with mammalian reoviruses. J Virol 1993; 67: 2055–2063
   Google Scholar
• Destombes J, Couderc T, Thiesson D, Girard S, Wilt S G, Blondel B. Persistent poliovirus infection in mouse motoneurons. J Virol 1997; 71: 1621–1628
   PubMedGoogle Scholar
• Diard C, Ravaud J F, Held J P. French survey of postpolio sequelae. Risk factors study and medical social outcome. Am J Phys Med Rehabil 1994; 73: 264–267
   Google Scholar
• Doedens J, Maynell L A, Klymkowsky M W, Kirkegaard K. Secretory pathway function, but not cytoskeletal integrity, is required in poliovirus infection. Arch Virol-Supp 1994; 9: 159–172
   Google Scholar
• Doedens J R, Kirkegaard K. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J 1995; 14: 894–907
   Google Scholar
• Dove A W, Racaniello V R. Cold-adapted poliovirus mutants bypass a postentry replication block. J Virol 1997; 71: 4728–4735
   Google Scholar
• Dunn G, Begg N T, Cammack N, Minor P D. Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources. J Med Virol 1990; 32: 92–95
   PubMed Web of Science ®Google Scholar
• Dunnebacke T H, Levinthal J D, Williams R C. Entry and release of poliovirus as observed by electron microscopy of cultured cells. J Virol 1969; 4: 505–513
   Google Scholar
• Eberle K E, Nguyen V T, Freistadt M S. Low levels of poliovirus replication in primary human monocytes: possible interactions with lymphocytes. Arch Virol 1995; 140: 2135–2150
   Google Scholar
• Enders J F, Weller T H, Robbins F C. Cultivation of Lansing strain of poliomyelitis virus in culture of various human embryonic tissues. Science 1949; 109: 85–87
   PubMed Web of Science ®Google Scholar
• Equestre M, Genovese D, Calvalieri F, Fiore L, Santoro R, Perez-Bercoff R. Identification of a consistent pattern of mutations in neurovirulent variants derived from the Sabin vaccine strain of poliovirus type 2. J Virol 1991; 65: 2707–2710
   Google Scholar
• Evans D M, Dunn G, Minor P D, Schild G C, Cann A J, Stanway G, Almond J W, Currey K, Maizel J V. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 1985; 314: 548–550
   PubMed Web of Science ®Google Scholar
• Everaert L, Vrijsen R, Boeyé A. Eclipse products of poliovirus after cold-synchronized infection of HeLa cells. Virology 1989; 171: 76–82
   Google Scholar
• Fagraeus A, Bottiger M, Heller L, Norrby E. Replication of poliovirus and measles virus in cultures of human lymphoblastoid and of Burkitt lymphoma cell lines. Arch Virol 1981; 69: 229–237
   Google Scholar
• Filman D J, Syed R, Chow M, Macadam A J, Minor P D, Hogle J M. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J 1989; 8: 1567–1579
   PubMed Web of Science ®Google Scholar
• Flore O, Fricks C E, Filman D J, Hogle J M. Conformational changes in poliovirus assembly and cell entry. Sem Virol 1990; 1: 429–438
   Google Scholar
• Freistadt M. Distribution of the poliovirus receptor in human tissue. Cellular receptors for animal viruses, E Wimmer. Cold Spring Harbor Laboratory Press, New York 1994; 445–461
   Google Scholar
• Freistadt M, Eberle K E. Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence. J Virol 1996; 70: 6486–6492
   Google Scholar
• Freistadt M S, Fleit H B, Wimmer E. Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication. Virology 1993; 195: 798–803
   PubMed Web of Science ®Google Scholar
• Freistadt M S, Kaplan G, Racaniello V R. Heterogenous expression of poliovirus receptor-related proteins in human cells and tissues. Mol Cell Biol 1990; 10: 5700–5706
   PubMedGoogle Scholar
• Fricks C E, Hogle J M. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VPl is responsible for liposome binding. J Virol 1990; 64: 1934–1945
   PubMed Web of Science ®Google Scholar
• Furione M, Guillot S, Otelea D, Balanant J, Candrea A, Crainic R. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 1993; 196: 199–208
   PubMed Web of Science ®Google Scholar
• Georgescu M M, Delpeyroux F, Tardy-Panit M, Balanant J, Combiescu M, Guillot S, Crainic R. High diversity of poliovirus strains isolated from the central nervous system of patients with vaccine-associated paralytic poliomyelitis. J Virol 1994; 68: 8089–8101
   PubMed Web of Science ®Google Scholar
• Georgescu M M, Tardy-Panit M, Guillot S, Crainic R, Delpeyroux F. Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus. J Virol 1995; 69: 5278–5286
   PubMed Web of Science ®Google Scholar
• Ghendon Y, Yakobson E, Mikhejeva A. Study of some stages of poliovirus morphogenesis in MiO cells. J Virol 1972; 10: 260–266
   Google Scholar
• Gingras A C, Svitkin Y, Belsham G J, Pause A, Sonenberg N. Activation of the translational suppressor 4E-BP1 following infection with encephalomyocarditis virus and poliovirus. Proc Natl Acad Sci USA 1996; 93: 5578–5583
   PubMedGoogle Scholar
• Gomez Yafal A, Kaplan G, Racaniello V R, Hogle J M. Characterization of poliovirus conformational alteration mediated by soluble receptors. Virology 1993; 197: 501–505
   Google Scholar
• Gromeier M, Alexander L, Wimmer E. Internal ribosomal entry site substitution eliminates neurovimlence in intergeneric poliovirus recombinants. Proc Natl Acad Sci USA 1996; 93: 2370–2375
   PubMed Web of Science ®Google Scholar
• Gromeier M, Lu H H, Wimmer E. Mouse neuropathogenic poliovirus strains cause damage in the central nervous system distinct from poliomyelitis. Microb Pathog 1995; 18: 253–267
   Google Scholar
• Gromeier M, Mueller S, Soleki D, Bossert B, Bernhardt G, Wimmer E. Determinants of poliovirus neurovirulence. J Neurovirol 1997; 3: 35–38
   Google Scholar
• Gromeier M, Wetz K. Kinetics of poliovirus uncoating in HeLa cells in a nonacidic environment. J Virol 1990; 64: 3590–3597
   Google Scholar
• Gutierrez A L, Denovaocampo M, Racaniello V R, Delangel R M. Attenuating mutations in the poliovirus 5' untranslated region alter its interaction with polypyrimidine tract-binding protein. J Virol 1997; 71: 3826–3833
   PubMed Web of Science ®Google Scholar
• Haller A, Semler B. Translation and host cell shutoff. Human enterovirus infection, H A Rotbart. ASM, Washington, DC 1995; 113–133
   Google Scholar
• Haller A A, Stewart S R, Semler B L. Attenuation stem-loop lesions in the 5' noncoding region of poliovirus RNA: neuronal cell-specific translation defects. J Virol 1996; 70: 1467–1474
   Google Scholar
• Hambidge S J, Sarnow P. Translational enhancement of the poliovirus 5'-noncoding region mediated by virus-encoded polypeptide-2A. Proc Natl Acad Sci USA 1992; 89: 10272–10276
   PubMedGoogle Scholar
• Hammerle T, Hellen C U, Wimmer E. Site-directed mutagenesis of the putative catalytic triad of poliovirus 3C proteinases. J Biol Chem 1991; 266: 5412–5416
   PubMedGoogle Scholar
• Harber J, Bernhardt G, Lu H H, Sgro J Y, Wimmer E. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor. Virology 1995; 214: 559–570
   PubMed Web of Science ®Google Scholar
• Hashimoto I, Hagiwara A, Komatsu T. Ultrastructural studies on the pathogenesis of poliomyelitis in monkeys infected with poliovirus. Acta Neuropathol 1984; 64: 53–60
   Google Scholar
• Hellen C, Wimmer E. Enterovirus structure and assembly. Human enterovirus infection, H A Rotbart. ASM, Washington, DC 1995; 155–174
   Google Scholar
• Hellen C U, Lee C K, Wimmer E. Determinants of substrate recognition by poliovirus-2A proteinase. J Virol 1992; 66: 3330–3338
   Google Scholar
• Hellen C U, Witherell G W, Schmid M, Shin S H, Pestova T V, Gil A, Wimmer E. A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc Natl Acad Sci USA 1993; 90: 7642–7646
   PubMedGoogle Scholar
• Hogle J M, Chow M, Filman D J. Three dimensional structure of poliovirus at 2.9 A resolution. Science 1985; 229: 1358–1365
   PubMed Web of Science ®Google Scholar
• Holland J J. Receptor affinities as major determinants of enterovirus tissue tropisms in humans. Virology 1961; 15: 312–326
   PubMedGoogle Scholar
• Holland J J, Kiehn E D. Specific cleavage of viral proteins as steps in the synthesis and maturation of enteroviruses. Proc Natl Acad Sci USA 1968; 60: 1015–1022
   Google Scholar
• Holland J J, McLaren L C. The mammalian cell virus relationship. II. Adsorption, reception, and eclipse by HeLa cells. J Exp Med 1959; 109: 487–504
   Google Scholar
• Holland J J, McLaren L C, Syverton J T. The mammalian cell virus relationship. III. Production of infectious poliovirus by non-primate cells exposed to poliovirus ribonucleic acid. Proc Soc Exp Biol Med 1959a; 100: 843–845
   Google Scholar
• Holland J J, McLaren L C, Syverton J T. The mammalian cell virus relationship. IV. Infection of naturally insusceptible cells with enterovirus ribonucleic acid. J Exp Med 1959b; 110: 65–80
   Google Scholar
• Horie H, Koike S, Kurata T, Satoyoshida Y, Ise I, Ota Y, Abe S, Hioki K, Kato H, Taya C, Nomura T, Hashizume S, Yonekawa H, Nomoto A. Transgenic mice carrying the human poliovirus receptor: new animal model for study of poliovirus neurovirulence. J Virol 1994; 68: 681–688
   Google Scholar
• Horstmann D M, Opton E M, Klemperer R. Viremia in infants vaccinated with oral poliovirus vaccine (Sabin). Am J Hyg 1964; 79: 47
   Google Scholar
• Hull H F, Birmingham M E, Melgaard B, Lee J W. Progress toward global polio eradication. J Infec Dis 1997; 175(Suppl 1)S4–S9
   Google Scholar
• Irurzun A, Arroyo J, Alvarez A, Carrasco L. Enhanced intracellular calcium concentration during poliovirus infection. J Virol 1995; 69: 5142–5146
   Google Scholar
• Jackson R, Hunt S, Gibbs C, Kaminski A. Internal initiation of translation of picornavirus RNAs. Mol Biol Rep 1994; 19: 147–159
   PubMed Web of Science ®Google Scholar
• Jackson R, Hunt S, Reynolds J, Kaminski A. Cap-dependent and cap-independent translation: operational distinctions and mechanistic interpretations. Curr Top Microbiol Immunol 1995; 203: 1–29
   PubMedGoogle Scholar
• Jacobson M F, Baltimore D. Morphogenesis of poliovirus. I. Association of the viral RNA with coat protein. J Mol Biol 1968; 33: 369–378
   Google Scholar
• Jacobson M F, Baltimore D. Further evidence on the formation of poliovirus proteins. J Mol Biol 1970; 49: 657–669
   PubMed Web of Science ®Google Scholar
• Jacobson S J, Konings D AM, Sarnow P. Biochemical and genetic evidence for a pseudoknot structure at the 3' terminus of the poliovirus RNA genome and its role in viral RNA amplification. J Virol 1993; 67: 2961–2971
   PubMedGoogle Scholar
• Joachims M, Etchison D. Poliovirus infection results in structural alteration of a microtubuleassociated protein. J Virol 1992; 66: 5797–5804
   Google Scholar
• Joachims M, Harris K S, Etchison D. Poliovirus protease 3C mediates cleavage of microtubule-associated protein 4. Virology 1995; 211: 451–461
   Google Scholar
• Johnson K, Sarnow P. Viral RNA synthesis. Human enterovirus infection, H A Rotbart. ASM, Washington, DC 1995; 95–112
   Google Scholar
• Johnson K L, Sarnow P. Three poliovirus 2B mutants exhibit noncomplementable defects in viral RNA amplification and display dosage-dependent dominance over wild-type poliovirus. J Virol 1991; 65: 4341–4349
   Google Scholar
• Jore J, De Geus B, Jackson R J, Pouwels P H, Enger-Valk B E. Poliovirus protein 3CD is the active protease for processing of the precursor P1 in vitro. J Gen Virol 1988; 69: 1627–1636
   Google Scholar
• Jubelt B, Gallez-Hawkins G, Narayan O, Johnson R T. Pathogenesis of human poliovirus infection in mice. I. Clinical and pathological studies. J Neuropathol Exp Neurol 1980; 39: 138–148
   PubMed Web of Science ®Google Scholar
• Jubelt B, Meagher J B. Poliovirus infection of cyclophosphamide-treated mice results in persistence and late paralysis. I. Virologic studies. Neurology 1984a; 34: 486–493
   Google Scholar
• Jubelt B, Meagher J B. Poliovirus infection of cyclophosphamide-treated mice results in persistence and late paralysis. II. Virologic studies. Neurology 1984b; 34: 494–499
   Google Scholar
• Kaplan G, Freistadt M S, Racaniello V R. Neutralization of poliovirus by cell receptors expressed in insect cells. J Virol 1990; 64: 4697–4702
   PubMedGoogle Scholar
• Kaplan G, Levy A, Racaniello V R. Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle. J Virol 1989; 63: 43–51
   Google Scholar
• Kawamura N, Kohara M, Abe S, Komatsu T, Tago K, Arita M, Nomoto A. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol 1989; 63: 1302–1309
   PubMed Web of Science ®Google Scholar
• Kean K M, Teterina N L, Marc D, Girard M. Analysis of putative active site residues of the poliovirus 3C protease. Virology 1991; 181: 609–619
   Google Scholar
• Kirkegaard K. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA. J Virol 1990; 64: 195–206
   Google Scholar
• Kitamura N, Semler B L, Rothberg P G, Larsen G R, Adler C J, Dorner A J, Emini E A, Hanecak R, Lee J J, Van der Werf S, Anderson C W, Wimmer E. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 1981; 291: 547–553
   PubMed Web of Science ®Google Scholar
• Kliewer S, Dasgupta A. An RNA polymerase II transcription factor inactivated in poliovirus-infected cells copurifies with transcription factor TFIID. Mol Cell Biol 1988; 8: 3175–3182
   PubMedGoogle Scholar
• Kliewer S, Muchardt C, Gaynor R B, Dasgupta A. Loss of a phosphorylated form of transcription factor CREBJATF in poliovirus-infected cells. J Virol 1990; 64: 4507–4517
   PubMedGoogle Scholar
• Koike S, Aoki J, Nomoto A. Transgenic mouse for the study of poliovirus pathogenicity. Cellular receptors for animal viruses, E Wimmer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 1994; 463–479
   Google Scholar
• Koike S, Horie H, Ise I, Okitsu A, Yoshida M, Iizuka N, Takeuchi K, Takegami T, Nomoto A. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J 1990; 9: 3217–3224
   PubMed Web of Science ®Google Scholar
• Koike S, Ise I, Nomoto A. Functional domains of the poliovirus receptor. Proc Natl Acad Sci USA 1991a; 88: 4104–4108
   Google Scholar
• Koike S, Ise I, Sato Y, Yonekawa H, Gotoh O, Nomoto A. A 2nd gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain. J Virol 1992; 66: 7059–7066
   PubMedGoogle Scholar
• Koike S, Taya C, Kurata T, Abe S, Ise I, Yonekawa H, Nomoto A. Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci, USA 1991b; 88: 951–955
   PubMed Web of Science ®Google Scholar
• Krausslich H G, Holscher C, Reuer Q, Harber J, Wimmer E. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity. J Virol 1990; 64: 2433–2436
   Google Scholar
• Krausslich H G, Nicklin M J, Toyoda H, Etchison D, Wimmer E. Poliovirus proteinase 2A induces cleavage of eukaryotic initiation factor 4F polypeptide p220. J Virol 1987; 61: 2711–2718
   PubMed Web of Science ®Google Scholar
• Kyuwa S, Stohlman S A. Pathogenesis of a neurotropic murine coronavirus, strain JHM in the central nervous system of mice. Sem Virol 1990; 1: 273–280
   Google Scholar
• La Monica N, Almond J W, Racaniello V R. A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J Virol 1987a; 61: 2917–2920
   Google Scholar
• La Monica N, Kupsky W J, Racaniello V R. Reduced mouse neurovirulence of poliovirus type 2 Lansing antigenic variants selected with monoclonal antibodies. Virology 1987b; 161: 429–437
   Google Scholar
• La Monica N, Meriam C, Racaniello V R. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J Virol 1986; 57: 515–525
   PubMed Web of Science ®Google Scholar
• La Monica N, Racaniello V R. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J Virol 1989; 63: 2357–2360
   Google Scholar
• Lama J, Carrasco L. Screening for membranepermeabilizing mutants of the poliovirus protein 3AB. J Gen Virol 1996; 77: 2109–2119
   Google Scholar
• Lama J, Paul A V, Harris K S, Wimmer E. Properties of purified recombinant poliovims protein 3AB as substrate for viral proteinases and as co-factor for RNA polymerase 3Dpol. J Biol Chem 1994; 269: 66–70
   Google Scholar
• Lama J, Sanz M A, Rodriguez P L. A role for 3AB protein in poliovirus genome replication. J Biol Chem 1995; 270: 14430–14438
   PubMed Web of Science ®Google Scholar
• Landsteiner K, Popper E. Mickroscopische präparate von einem menschlichen und zwei affentückernmarker. Wien klin Wschr 1908; 21: 1830
   Google Scholar
• Lee C K, Nomoto A, Detjen B M, Wimmer E. A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci USA 1977; 74: 59–63
   PubMed Web of Science ®Google Scholar
• Lenk R, Penman S. The cytoskeletal framework and poliovirus metabolism. Cell 1979; 16: 289–301
   PubMed Web of Science ®Google Scholar
• Lentz K N, Smith A D, Geisler S C, Cox S, Buontempo P, Skelton A, Demartino J, Rozhon E, Schwartz J, Girijavallabhan V, O'Connell J, Arnold E. Structure of poliovirus type 2 Lansing complexed with antiviral agent sch48973 - comparison of the structural and biological properties of the three poliovirus serotypes. Structure 1997; 5: 961–978
   PubMed Web of Science ®Google Scholar
• Leon-Monzon M E, Dalakas M C. Detection of poliovirus antibodies and poliovirus genome in patients with post-polio syndrome (PPS). The post-polio syndrome, M C Dalakas, H Bartfeld, L T Kurland. The New York Academy of Sciences, New York 1995; 753: 208–218
   Google Scholar
• Leparc-Goffart I, Julien J, Fuchs F, Janatova I, Aymard M, Kopecka H. Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome. J Clin Microbiol 1996; 34: 2023–2026
   Google Scholar
• Li C P, Schaeffer M. Adaptation of type 1 poliomyelitis virus to mice. Proc Soc Exp Biol Med 1953; 82: 477–481
   PubMedGoogle Scholar
• Li J, Zhang L B, Yoneyama T, Yoshida H, Shimizu H, Yoshii K, Hara M, Nomura T, Yoshikura H, Miyamura T, Hagiwara A. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccineassociated paralytic patients. Arch Virol 1996; 141: 1047–1054
   Google Scholar
• Li J P, Baltimore D. An intragenic revertant of a poliovirus 2C mutant has an uncoating defect. J Virol 1990; 64: 1102–1107
   Google Scholar
• Lloyd R E, Bovee M. Persistent infection of human erythroblastoid cells by poliovirus. Virology 1993; 194: 200–209
   Google Scholar
• Lonberg-Holm K L, Gosser L B, Kauer J J. Early alteration of poliovirus in infected cells and its specific inhibition. J Gen Virol 1975; 27: 329–342
   Google Scholar
• Lonberg-Holm K L, Gosser L B, Shimshick E J. Interaction of liposomes with subviral particles of poliovirus type 2 and rhinovirus type 2. J Virol 1976; 19: 746–749
   Google Scholar
• Lopez-Rivas A, Castrillo J L, Carrasco L. Cation content in poliovirus-infected HeLa cells. J Gen Virol 1987; 68: 335–342
   Google Scholar
• Lu H H, Yang C F, Murdin A D, Klein M H, Harber J J, Kew O M, Wimmer E. Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VPl and proteinase 2Apro. J Virol 1994; 68: 7507–7515
   Google Scholar
• Lu Z, Asher D, Levenbook I, Chumakov K. Succession of mutations in the Sabin strain of type 3 poliovirus replicating in the central nervous system of monkeys. Virology 1996; 220: 285–289
   Google Scholar
• Lwoff A. Factors influencing the evolution of viral diseases at the cellular level and in the organism. Bacteriol Rev 1959; 23: 109–124
   PubMedGoogle Scholar
• Macadam A, Stone D M, Almond J W, Minor P D. The 5' noncoding region and virulence of poliovirus vaccine strains. Tren Microbiol 1994a; 2: 449–454
   Google Scholar
• Macadam A J, Arnold C, Howlett J, John A, Marsden S, Taffs F, Reeve P, Hamada N, Wareham K, Almond J, Cammack N, Minor P D. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology 1989; 172: 408–414
   PubMed Web of Science ®Google Scholar
• Macadam A J, Ferguson G, Arnold C, Minor P D. An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type-3 vaccine strain. J Virol 1991a; 65: 5225–5231
   Google Scholar
• Macadam A J, Ferguson G, Burlison J, Stone D, Skuce R, Almond J W, Minor P D. Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture. Virology 1992; 189: 415–422
   Google Scholar
• Macadam A J, Ferguson G, Fleming T, Stone D M, Almond J W, Minor P D. Role for poliovirus protease 2A in cap independent translation. EMBO J 1994b; 13: 924–927
   PubMedGoogle Scholar
• Macadam A J, Pollard S R, Ferguson G, Dunn G, Skuce R, Almond J W, Minor P D. The 5' noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology 1991b; 181: 451–458
   PubMed Web of Science ®Google Scholar
• Macadam A J, Pollard S R, Ferguson G, Skuce R, Wood D, Almond J W, Minor P D. Genetic basis of attenuation of the Sabin type 2 vaccint; strain of poliovirus in primates. Virology 1993; 192: 18–26
   PubMed Web of Science ®Google Scholar
• Marc D, Drugeon G, Haenni A L, Girard M, Van der Werf S. Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence. EMBO J 1989; 8: 2661–2668
   Google Scholar
• Martin A, Bénichou D, Couderc T, Hogle J, Wychowski C, Van der Werf S, Girard M. Use of type 1/ type 2 chimeric polioviruses to study determinants of poliovirus type 1 neurovirulence in a mouse model. Virology 1991; M180: 648–658
   Google Scholar
• Martin A, Wychowski C, Couderc T, Crainic R, Hogle J, Girard M. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimeric virus which is neurovirulent for mice. EMBO J 1988; 7: 2839–2847
   Google Scholar
• McBride A E, Schlegel A, Kirkegaard K. Human protein Sam68 relocalization and interaction with poliovirus RNA polymerase in infected cells. Proc Nat! Acad Sci USA 1996; 93: 2296–2301
   PubMed Web of Science ®Google Scholar
• McGoldrick A, Macadam A J, Dunn G, Rowe A, Burlison J, Minor P D, Meredith J, Evans D J, Almond J W. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus. J Virol 1995; 69: 7601–7605
   Google Scholar
• Meerovitch K, Svitkin Y V, Lee H S, Lejbkowicz F, Kenan D J, Chan E K, Agol V I, Keene J D, Sonenberg N. La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J Virol 1993; 67: 3798–3807
   PubMed Web of Science ®Google Scholar
• Mendelsohn C L, Wimmer E, Racaniello V R. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily. Cell 1989; 56: 855–865
   PubMed Web of Science ®Google Scholar
• Miller J R. Prolonged intracerebral infection with poliovirus in asymptomatic mice. Ann Neurol 1981; 9: 590–596
   Google Scholar
• Minor P. Classification and nomenclature of viruses. Fifth report of the international committee of taxonomy of viruses, R IB Francki. Springer-Verlag, New York 1991; 320–326
   Google Scholar
• Minor P. Poliovirus. Viral pathogenesis, N Nathanson. Lippincott-Raven Publishers, Philadelphia 1997; 555–574
   Google Scholar
• Minor P D. The molecular biology of poliovaccines. J Gen Virol 1992; 73: 3065–3077
   PubMedGoogle Scholar
• Minor P D. Poliovirus biology. Structure 1996; 4: 775–778
   Google Scholar
• Minor P D, Dunn G. The effect of sequences in the 5' non-coding region on the replication of polioviruses in the human gut. J Gen Virol 1988; 69: 1091–1096
   PubMed Web of Science ®Google Scholar
• Mirzayan C, Wimmer E. Biochemical studies on poliovirus polypeptide 2C: evidence for ATPase activity. Virology 1994; 199: 176–187
   Google Scholar
• Modlin J. Poliomyelitis and poliovirus immunization. Human enterovirus infections, H A Rotbart. ASM Press, Washington, DC 1995; 195–220
   Google Scholar
• Molla A, Paul A V, Schmid M, Jang S K, Wimmer E. Studies on dicistronic polioviruses implicate viral proteinase 2Apro in RNA replication. Virology 1993; 196: 739–747
   PubMedGoogle Scholar
• Morrison M E, He Y J, Wien M W, Hogle J M, Racaniello V R. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J Virol 1994; 68: 2578–2588
   PubMedGoogle Scholar
• Morrison M E, Racaniello V R. Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene. J Virol 1992; 66: 2807–2813
   PubMedGoogle Scholar
• Moss E G, O'Neill R E, Racaniello V R. Mapping of attenuating sequences of an avirulent poliovirus type 2 strain. J Virol 1989; 63: 1884–1890
   Google Scholar
• Moss E G, Racaniello V R. Host range determinants located on the interior of the poliovirus capsid. EMBO J 1991; 10: 1067–1074
   Google Scholar
• Mosser A G, Caliguiri L A, Tamm I. Incorporation of lipid precursors into cytoplasmic membranes of poliovirus-infected HeLa cells. Virology 1972; 47: 39–47
   Google Scholar
• Mosser A G, Sgro J Y, Rueckert R R. Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions. J Virol 1994; 68: 8193–8201
   Google Scholar
• Muir P, Nicholson F, Sharief M K, Thompson E J, Cairns N J, Lantos P, Spencer G T, Kaminski H J, Banatvala J E. Evidence for persistent enterovirus infection of the central nervous system in patients with previous paralytic poliomyelitis. The post-polio syndrome, M C Dalakas, H Bartfeld, L T Kurland. The New York Academy of Sciences, New York 1995; 753: 219–232
   Google Scholar
• Mulders M N, Lipskaya G Y, Vanderavoort H GAM, Koopmans M PG, Kew O M, Vanloon A M. Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East, and the Indian subcontinent. J Infect Dis 1995; 171: 1399–1405
   Google Scholar
• Munoz A, Carrasco L. Effect of interferon treatment on blockade of protein synthesis induced by poliovirus infection. Eur J Biochem 1983; 137: 623–629
   Google Scholar
• Murray M G, Bradley J, Yang X F, Wimmer E, Moss E G, Racaniello V R. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site 1. Science 1988; 241: 213–215
   Google Scholar
• Nakano J H, Hatch M H, Thieme M L, Nottay B. Parameters for differentiating vaccine-derived and wild poliovirus strains. Prog Med Virol 1978; 24: 178–206
   Google Scholar
• Neufeld K L, Galarza J M, Richards O C, Summers D F, Ehrenfeld E. Identification of terminal adenylyl transferase activity of the poliovirus polymerase 3Dpol. J Virol 1994; 68: 5811–5818
   Google Scholar
• Nomoto A, Omata T, Toyoda H, Kuge S, Horie H, Kataoka Y, Genba Y, Nakano Y, Imura N. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci USA 1982; 79: 5793–5797
   PubMedGoogle Scholar
• Novoa I, Feduchi E, Carrasco L. Hybrid proteins between Pseudomonas exotoxin A and poliovirus protease 2A(pro). FEBS Lett 1994; 355: 45–48
   PubMedGoogle Scholar
• Nugent C I, Kirkegaard K. RNA binding properties of poliovirus subviral particles. J Virol 1995; 69: 13–22
   Google Scholar
• O'Neill R E, Racaniello V R. Inhibition of translation in cells infected with a poliovirus 2Apro mutant correlates with phosphorylation of the alpha subunit of eucaryotic initiation factor 2. J Virol 1989; 63: 5069–5075
   PubMed Web of Science ®Google Scholar
• Oldstone M BA. Viral persistence. Cell 1989; 56: 517–520
   PubMed Web of Science ®Google Scholar
• Olson N H, Kolatkar P R, Oliveira M A, Cheng R H, Greve J M, McClelland A, Baker T S, Rossmann M G. Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci USA 1993; 90: 507–511
   PubMed Web of Science ®Google Scholar
• Omata T, Kohara M, Kuge S, Komatsu T, Abe S, Semler B L, Kameda A, Itoh H, Arita M, Wimmer E, Nomoto A. Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol 1986; 58: 348–358
   PubMedGoogle Scholar
• Otelea D, Guillot S, Furione M, Combiescu A A, Balanant J, Candrea A, Crainic R. Genomic modifications in naturally occuring neurovirulent revertants of Sabin 1 polioviruses. Dev Biol Stand 1993; 78: 33–38
   PubMedGoogle Scholar
• Pasca S. Poliovirus-carrying lines of HeLa cells: their establishment and sensitivity to viruses. Acta Microbiol Hung 1961; 4: 329–332
   Google Scholar
• Pavio N, Buc-Caron M H, Colbere-Garapin F. Persistent poliovirus infection of human fetal brain cells. J Virol 1996; 70: 6395–6401
   Google Scholar
• Pelletier I, Couderc T, Borzakian S, Wyckoff E, Crainic R, Ehrenfeld E, Colbere-Garapin F. Characterization of persistent poliovirus mutants selected in human neuroblastoma cells. Virology 1991; 180: 729–737
   Google Scholar
• Pelletier J, Kaplan G, Racaniello V R, Sonenberg N. Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5'-noncoding region. Mol Cell Biol 1988; 8: 1103–1112
   PubMed Web of Science ®Google Scholar
• Pelletier J, Sonenberg N. Internal binding of eucaryotic ribosomes on poliovirus RNA: translation in HeLa cell extracts. J Virol 1989; 63: 441–444
   PubMedGoogle Scholar
• Perez L, Carrasco L. Entry of poliovirus into cells does not require a low-pH step. J Virol 1993; 67: 4543–4548
   Google Scholar
• Pfister T, Pasamontes L, Troxler M, Egger D, Bienz K. Immunocytochemical localization of capsidrelated particles in subcellular fractions of poliovirusinfected cells. Virology 1992; 188: 676–684
   Google Scholar
• Phillips B A, Fennel R. Polypeptide composition of poliovirions, naturally occuring empty capsids, 14S precursor proteins. J Virol 1973; 12: 291–299
   PubMed Web of Science ®Google Scholar
• Pilipenko E V, Blinov V M, Romanova L I, Sinyakov A N, Maslova S V, Agol V I. Conserved structural domains in the 5'-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology 1989; 168: 201–209
   PubMedGoogle Scholar
• Pilipenko E V, Gmyl A P, Maslova S V, Svitkin Y V, Sinyakov A N, Agol V I. Prokaryotic-like cis elements in the cap-independent internal initiation of translation on picomavims RNA. Cell 1992; 68: 119–131
   PubMed Web of Science ®Google Scholar
• Pilipenko E V, Poperechny K V, Maslova S V, Melchers W JG, Slot H JB, Agol V I. Cis-element oriR, involved in the initiation of (-) strand poliovirus RNA: a quasi-globular multi-domain RNA structure maintained by tertiary (kissing) interactions. EMBO J 1996; 15: 5428–5436
   Google Scholar
• Plotch S J, Palant O. Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3D(pol). J Virol 1995; 69: 7169–7179
   PubMed Web of Science ®Google Scholar
• Racaniello V, Ren R. Poliovirus biology and pathogenesis. Curr Top Microbiol Immunol 1996; 206: 305–325
   Google Scholar
• Racaniello V R. The poliovirus receptor: a hook, or an unzipper?. Structure 1996; 4: 769–773
   Google Scholar
• Racaniello V R, Baltimore D. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci USA 1981; 78: 4887–4891
   PubMed Web of Science ®Google Scholar
• Ren R, Moss E G, Racaniello V R. Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J Virol 1991; 65: 1377–1382
   PubMed Web of Science ®Google Scholar
• Ren R, Racaniello V R. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol 1992a; 66: 296–304
   PubMed Web of Science ®Google Scholar
• Ren R, Racaniello V R. Poliovirus spreads from muscle to the central nervous system by neural pathways. J Infect Dis 1992b; 166: 747–752
   PubMed Web of Science ®Google Scholar
• Ren R B, Costantini F, Gorgacz E J, Lee J J, Racaniello V R. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 1990; 63: 353–362
   PubMed Web of Science ®Google Scholar
• Rezapkin G V, Chumakov K M, Lu Z B, Ran Y X, Dragunsky E M, Levenbook I S. Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Virology 1994; 202: 370–378
   Google Scholar
• Rezapkin G V, Norwood L P, Taffs R E, Dragunsky E M, Levenbook I S, Chumakov K M. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control. Virology 1995; 211: 377–384
   Google Scholar
• Rodriguez P L, Carrasco L. Poliovirus protein-2C has ATPase and GTPase activities. J Biol Chem 1993; 268: 8105–8110
   Google Scholar
• Roehl H H, Semler B L. Poliovirus infection enhances the formation of two ribonucleoprotein complexes at the 3' end of viral negative-strand RNA. J Virol 1995; 69: 2954–2961
   PubMed Web of Science ®Google Scholar
• Rohll J B, Percy N, Ley R, Evans D J, Almond J W, Barclay W S. The 5'-untranslated regions of picorna-virus RNAs contain independent functional domains essential for RNA replication and translation. J Virol 1994; 68: 4384–4391
   PubMed Web of Science ®Google Scholar
• Ron D, Tal J. Coevolution of cells and virus as a mechanism for the persistence of lymphotropic minute virus of mice in L cells. J Virol 1985; 55: 424–430
   Google Scholar
• Rossmann M G, Arnold E, Erickson J W, Frankenberger E A, Griffith J P, Hecht J H, Johnson J E, Kamer G, Luo M, Mosser A G, Rueckert R R, Sherry B, Vriend G. Structure of a human common cold virus and functional relationships to other picomaviruses. Nature 1985; 317: 145–153
   PubMed Web of Science ®Google Scholar
• Rubinstein S J, Dasgupta A. Inhibition of rRNA synthesis by poliovirus: specific inactivation of transcription factors. J Virol 1989; 63: 4689–4696
   PubMed Web of Science ®Google Scholar
• Rueckert R, Wimmer E. Systematic nomenclature of picornavirus proteins. J Virol 1984; 50: 957–959
   PubMed Web of Science ®Google Scholar
• Rueckert R R. Picornaviridae and their replication. Virology, B N Fields, D M Knipe, P M Howley. Raven Press Ltd, New York 1996; 1: 609–654
   Google Scholar
• Sabin A B. Pathogenesis of poliomyelitis. Reappraisal in the light of new data. Science 1956; 123: 1151–1157
   PubMed Web of Science ®Google Scholar
• Sabin A B. Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis 1985; 151: 420–436
   PubMed Web of Science ®Google Scholar
• Sabin A B, Boulger L R. History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand 1973; 1: 115–118
   Google Scholar
• Salk J E. Consideration in the preparation and use of poliomyelitis virus vaccine. J Amer Med Ass 1955; 1548: 1239–1248
   Google Scholar
• Schlegel A, Giddings T H, Ladinsky M S, Kirkegaard K. Cellular origin and ultrastructure of membranes induced during poliovirus infection. J Virol 1996; 70: 6576–6588
   PubMed Web of Science ®Google Scholar
• Schlegel A, Kirkegaard K. Cell biology of enterovirus infection. Human enterovirus infection, H A Rotbart. ASM, Washington, DC 1995; 135–154
   Google Scholar
• Schneider-Schaulies S, ter Meulen V. Molecular aspects of measles virus induced central nervous system disease. Molecular Neurovirology, R P Roos. Human Press Inc, Totowa, New Jersey 1992; 419–449
   Google Scholar
• Selinka H C, Zibert A, Wimmer E. Poliovirus can enter and infect mammalian cells by way of an intercellular adhesion molecule 1 pathway. Proc Natl Acad Sci USA 1991; 88: 3598–3602
   Google Scholar
• Selinka H C, Zibert A, Wimmer E. A chimeric poliovirusJCD4 receptor confers susceptibility to poliovirus on mouse cells. J Virol 1992; 66: 2523–2526
   Google Scholar
• Sharief M K, Hentges M R, Ciardi M. tntrathecal immune response in patients with the post-polio syndrome. N Engl J Med 1991; 325: 749–755
   Google Scholar
• Shiroki K, Ishii T, Aoki T, Kobashi M, Ohka S, Nomoto A. A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA. J Virol 1995; 69: 6825–6832
   Google Scholar
• Shiroki K, Ishii T, Aoki T, Ota Y, Yang W X, Komatsu T, Ami Y, Arita M, Abe S, Hashizume S, Nomoto A. Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA. J Virol 1997; 71: 1–8
   PubMed Web of Science ®Google Scholar
• Shiroki K, Kato H, Koike S, Odaka T, Nomoto A. Temperature-sensitive mouse cell factors for strandspecific initiation of poliovirus RNA synthesis. J Virol 1993; 67: 3989–3996
   Google Scholar
• Sicinski P, Rowinski J, Warchol J B, Jarzabek Z, Gut W, Szczygiel B, Bielicki K, Koch G. Poliovirus type 1 enters the human host through intestinal M cells. Gastroenterology 1990; 98: 56–58
   PubMed Web of Science ®Google Scholar
• Skinner M A, Racaniello V R, Dunn G, Cooper J, Minor P D, Almond J W. New model for the secondary structure of the 5'-noncoding RNA of poliovirus is supported by biochemical and genetic data that also shows that RNA secondary structure is important in neurovirulence. J Mol Biol 1989; 207: 379–392
   PubMed Web of Science ®Google Scholar
• Slobodskaya O R, Gmyl A P, Maslova S V, Tolskaya E A, Viktorova E G, Agol V I. Poliovirus neurovirulence correlates with the presence of a cryptic AUG upstream of the initiator codon. Virology 1996; 221: 141–150
   PubMedGoogle Scholar
• Sommergruber W, Ahorn H, Klump H, Seipelt J, Zoephel A, Fessl F, Krystek E, Blaas D, Kuechler E, Liebig H D, Skern T. 2A proteinases of coxsackie- and rhinovirus cleave peptides derived from eIF-4 gamma via a common recognition motif. Virology 1994; 198: 741–745
   PubMedGoogle Scholar
• Sonenberg N. Regulation of translation by poliovirus. Adv Virol Res 1987; 33: 175–204
   PubMedGoogle Scholar
• Stanway G, Cann A J, Hauptmann R, Hughes P, Clarke L D, Mountford R C, Minor P D, Schild G C, Almond J W. The nucleotide sequence of poliovirus type 3 Leon 12alb: comparison with poliovirus type 1. Nucleic Acids Res 1983; 11: 5629–5643
   PubMed Web of Science ®Google Scholar
• Stanway G, Hughes P J, Mountford R C, Reeve P, Minor P D, Schild G C, Almond J W. Comparison of the complete nucleotide sequence of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a, b. Proc Natl Acad Sci USA 1984; 81: 1539–1543
   PubMed Web of Science ®Google Scholar
• Strebel P M, Aubertcombiescu A, Ionnedelcu N, Biberimoroeanu S, Combiescu M, Sutter R W, Kew O M, Pallansch M A, Patriarca P A, Cochi S L. Paralytic poliomyelitis in Romania, 1984–1992: evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol 1994; 140: 1111–1124
   Google Scholar
• Strebel P M, Sutter R W, Pallansch M A, Cochi S L. Intramuscular injections and vaccine-associated poliomyelitis - Reply. N Engl J Med 1995; 333: 64
   Google Scholar
• Svitkin Y V, Cammack N, Minor P D, Almond J W. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472 → U. Virology 1990; 175: 103–109
   Google Scholar
• Svitkin Y V, Pestova T V, Maslova S V, Agol V I. Point mutations modify the response of poliovirus RNA to a translation initiation factor: a comparison of neurovirulent and attenuated strains. Virology 1988; 166: 394–404
   PubMedGoogle Scholar
• Taffs R E, Chumakov K M, Rezapkin G V, Lu Z B, Douthitt M, Dragunsky E M, Levenbook I S. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions. Virology 1995; 209: 366–373
   Google Scholar
• Tardy-Panit M, Blondel B, Martin A, Tekaia F, Horaud F, Delpeyroux F. A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. J Virol 1993; 67: 4630–4638
   Google Scholar
• Tatem J M, Weeks-Levy C, Georgiu A, Dimichele S J, Gorgacz E J, Racaniello V R, Cano F R, Mento S J. A mutation present in the amino terminus of Sabin-3 poliovirus VP1 protein is attenuating. J Virol 1992; 66: 3194–3197
   PubMed Web of Science ®Google Scholar
• Teterina N L, Kean K M, Gorbalenya A E, Agol V I, Girard M. Analysis of the functional significance of amino acid residues in the putative NTP-binding pattern of the poliovirus-2C protein. J Gen Virol 1992; 73: 1977–1986
   Google Scholar
• Tolskaya E A, Ivannikova T A, Kolesnikova M S, Drozdov S G, Agol V I. Postinfection treatment with antiviral serum results in survival of neural cells productively infected with virulent poliovirus. J Virol 1992; 66: 5152–5156
   Google Scholar
• Tolskaya E A, Romanova L, Kolesnikova M S, Ivannikova T A, Smirnova E A, Raikhlin N T, Agol V I. Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J Virol 1995; 69: 1181–1189
   PubMed Web of Science ®Google Scholar
• Tosteson M T, Chow M. Characterization of the ion channels formed by poliovirus in planar lipid membranes. J Virol 1997; 71: 507–511
   Google Scholar
• Towner J S, Ho T V, Semler B L. Determinants of membrane association for poliovirus protein 3AB. J Biol Chem 1996; 271: 26810–26818
   PubMed Web of Science ®Google Scholar
• Toyoda H, Kohara M, Kataoka Y, Suganuma T, Omata T, Imura I, Nomoto A. Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol 1984; 174: 561–585
   PubMed Web of Science ®Google Scholar
• Toyoda H, Yang C F, Takeda N, Nomoto A, Wirnmer E. Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach. J Virol 1987; 61: 2816–2822
   Google Scholar
• Trono D, Andino R, Baltimore D. An RNA sequence of hundreds of nucleotides at the 5' end of poliovirus RNA is involved in allowing viral protein synthesis. J Virol 1988; 62: 2291–2299
   PubMedGoogle Scholar
• Tucker S P, Thornton C L, Wimmer E, Compans R W. Vectorial release of poliovirus from polarized human intestinal epithelial cells. J Virol 1993; 67: 4274–4282
   PubMed Web of Science ®Google Scholar
• Van der Werf S. Poliovirus. Synthetic vaccines, B H Nicholson. Blackwell Scientific Publications, Oxford 1994; 494–531
   Google Scholar
• Wallace R E. Susceptibility of human lymphoblasts (RPMI 7466) to viral infections in vitro. Proc Soc Exp Biol Med 1969; 130: 702–710
   Google Scholar
• Watanabe Y, Watanabe K, Katagiri K, Hinuma Y. Virus-specific proteins produced in HeLa cells infected with poliovirus: characterization of a subunit-like protein. J Biochem 1965; 57: 733–741
   Google Scholar
• Wenner H A, Kamitsuka P. Primary sites of virus multiplication following intra-muscular inoculation of poliomyelitis in Cynomolgus monkeys. Virology 1957; 3: 429–443
   Google Scholar
• Westrop G D, Wareham K A, Evans D MA, Dunn G, Minor P D, Magrath D I, Taffs F, Marsden S, Skinner M A, Schild G C, Almond J W. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol 1989; 63: 1338–1344
   PubMed Web of Science ®Google Scholar
• WHO. Requirements for poliomyelitis vaccine (oral). WHO Technical Report series 1990; 800: 30–65
   Google Scholar
• WHO. Poliomyelitis outbreak, Albania. Wkly Epidemiol Rec 1996; 39: 293–295
   Google Scholar
• Wiegers K, Uhlig H, Dernick R. NAg1B of poliovirus type 1: A discontinuous epitope formed by two loops of VP1 comprising residues 96–104 and 141–152. Virology 1989; 170: 583–586
   Google Scholar
• Wien M W, Chow M, Hogle J M. Poliovirus: New insights from an old paradigm. Structure 1996; 4: 763–767
   Google Scholar
• Wimmer E, Harber J, Bibb J, Gromeier M, Lu H H, Beinhardt G. Poliovirus receptor. Cellular receptors for animal viruses, E Wimmer. Cold Spring Harbor Laboratory Press, New York 1994; 101–127
   Google Scholar
• Wimmer E, Hellen C U, Cao X M. Genetics of poliovirus. Ann Rev Genet 1993; 27: 353–436
   PubMed Web of Science ®Google Scholar
• Wyatt H V. Incubation of poliomyelitis as calculated from the time of entry into the central nervous system via the peripheral nerve pathways. Rev Infect Dis 1990; 12: 547–556
   Google Scholar
• Wyckoff E E, Hershey J WB, Ehrenfeld E. Eukaryotic initiation factor-3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor-4F. Proc Natl Acad Sci USA 1990; 87: 9529–9533
   PubMedGoogle Scholar
• Wyckoff E E, Lloyd R E, Ehrenfeld E. The relationship of eukaryotic initiation factor-3 to the poliovirusinduced p220 cleavage activity. J Virol 1992; 66: 2943–2951
   PubMedGoogle Scholar
• Yalamanchili P, Datta U, Dasgupta A. Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3C(pro). J Virol 1997; 71: 1220–1226
   Google Scholar
• Yalamanchili P, Harris K, Wimmer E, Dasgupta A. Inhibition of basal transcription by poliovirus: a virusencoded protease (3Cpro) inhibits formation of TBPTATA box complex in vitro. J Virol 1996; 70: 2922–2929
   Google Scholar
• Yeates T O, Jacobson D H, Martin A, Wychowski C, Girard M, Filman D J, Hogle J M. Three-dimensional structure of a mouse-adapted type-2/type-1 poliovirus chimera. EMBO J 1991; 10: 2331–2341
   Google Scholar
• Ypma-Wong M F, Dewalt P G, Johnson V H, Lamb J G, Sender B L. Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology 1988; 166: 265–270
   Google Scholar
• Yu S F, Benton P, Bovee M, Sessions J, Lloyd R E. Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity. J Virol 1995; 69: 247–252
   PubMedGoogle Scholar
• Zeichardt H, Wetz K, Willingmann P, Habermehl K O. Entry of poliovirus type 1 and mouse Elberfeld (ME) virus into HEp-2 cells: receptor mediated endocytosis and endosomal or lysosomal uncoating. J Gen Virol 1985; 66: 483–492
   Google Scholar
• Zhang S, Racaniello V R. Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut. J Virol 1997; 71: 4915–4920
   PubMed Web of Science ®Google Scholar
• Zimmerman E F, Heeter M, Darnell J E. RNA synthesis in poliovirus-infected cells. Virology 1963; 19: 400–408
   PubMedGoogle Scholar